Current Problems in Cancer
Volume 29, Issue 6 , Pages 278-284 , November 2005

Optimal Timing for QOL Assessments

  • Kelli Burger, BS
  • ,
  • Sumithra Mandrekar, PhD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Dr. Jeff A. Sloan, Mayo Clinic, Section of Biostatistics, Department of Health Science Research, 200 First St. S.W., Rochester, MN 55905, USA

References 

  1. Cleeland CS , Ryan KM . Pain assessment (global use of the Brief Pain Inventory) . Ann Acad Med Singapore . 1994;23:129–138
  2. Sloan JA , Loprinzi CL , Novotny PJ , Barton DL , Lavasseur BI , Windschitl H . Methodologic lessons learned from hot flash studies . J Clin Oncol . 2001;19(23):4280–4290
  3. Curran SL , Andrykowski MA , Studts JL . Short form of the profile of mood states (POMS-SF) (psychometric information) . Psychol Assess . 1995;7(1):80–83
  4. Kilgore WDS . The visual analogue mood scale (can a single-item scale accurately classify depressive mood state?) . Psychol Rep . 1999;85(3):1238–1243
  5. McKenzie N , Marks I . Quick rating of depressed mood in patients with anxiety disorders . Br J Psychiatry . 1999;174:266–269
  6. Osoba D , Zee B , Pater J , Pater J , Warr D , Latreille J , et al.   Determinants of postchemotherapy nausea and vomiting in patients with cancer . J Clin Oncol . 1997;15:116–123
  7. Apfel CC , Kortila K , Abdalla M , Kerger H , Turan A , Vedder I , et al.   A factorial trial of six interventions for the prevention of postoperative nausea and vomiting . N Engl J Med . 2004;350:2441–2451
  8. Witzig TE , Silberstein PT , Loprinzi CL , Sloan JA , Novotny PJ , Mailliard JA , et al.   A phase III randomized double-blind study of epoetin alfa versus placebo in anemic patients with cancer undergoing chemotherapy . J Clin Oncol . 2005;23(12):2606–2617
  9. Day R , Ganz PA , Costantino JP , Cronin WM , Wickerham DL , Fisher B . Health-related quality of life and tamoxifen in breast cancer prevention (a report for the National Surgical Adjuvant Breast and Bowel Project P-1 Study) . J Clin Oncol . 1999;17(9):2659–2669
  10. Goldberg RM , Sargent DJ , Morton RF , Fuchs CS , Ramanathan RK , Williamson SK , et al.   A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer . J Clin Oncol . 2004;22:23–30
  11. Croghan GA , Sloan JA , Croghan IT , Novotny P , Hurt RD , DeKrey WL , et al.   Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers (a minimal intervention, randomized multicenter trial in a nonspecialized setting) . Nicotine Tob Res . 2003;5(2):181–187
  12. Beaver K , Luker KA , Owens RG , Leinster SJ , Degner LF , Sloan JA . Treatment decision making in women newly diagnosed with breast cancer . Cancer Nurs . 1996;19(1):8–19
  13. Degner L , Sloan JA . Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer . J Pain Symptom Manage . 1995;10:1–8
  14. Loprinzi CL , Goldberg RM , Su JQ , Mailliard JA , Kuross SA , Maksymiuk AW , et al.   Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer . J Clin Oncol . 1994;12:1126–1129
  15. Charboneau W , Goetz MP , Rubin J , Wong GY , Sloan JA , Novotny PJ , et al.   Painful metastases involving bone (feasibility of percutaneous CT and US guided radio frequency ablation) . Radiology . 2004;224(1):87–97
  16. Svobodnik A , Yang P , Novotny PJ , Bass E , Garces YI , Jett JR , et al.   Quality of life in 650 lung cancer survivors 6 months to 4 years after diagnosis . Mayo Clin Proc . 2004;79(8):1024–1030
  17. Loprinzi CL , Sloan JA , Rowland KM . Methodologic issues regarding cancer anorexia/cachexia trials. Research and palliative care: methodologies and outcomes . In:  Portenoy RK ,  Bruera E editor. Issues in Palliative Care Research . New York, NY: Oxford University Press; 2003;p. 25–40
  18. Sprangers MAG , Moinpour CM , Moyniyhan TJ , Patrick DL , Revicki DA , Sloan JA , et al.   Assessing meaningful changes in quality of life over time (a user’s guide for clinicians) . Mayo Clin Proc . 2002;77:561–571
  19. Goetz MP , Callstrom MR , Charboneau JW , Farrell MA , Maus TP , Welch TJ , et al.   Percutaneous image-guided radiofrequency ablation of painful metastases involving bone (a multicenter study) . J Clin Oncol . 2004;22(2):300–306
  20. Pater J, Osoba D, Zee B, Lofters W, Gore M, Dempsey , et al  Effects of altering the time of administration and the time frame of quality of life assessments in clinical trials (an example using the EORTC QLQ-C30 in a large anti-emetic trial) . Qual Life Res . 1998;7:273–278

PII: S0147-0272(05)00056-5

doi: 10.1016/j.currproblcancer.2005.09.002

Current Problems in Cancer
Volume 29, Issue 6 , Pages 278-284 , November 2005